News

A committee of the European Medicines Agency (EMA) has recommended that Kayshild (semaglutide), marketed in the U.S. and Canada as Wegovy, be approved in…

Half of biliary atresia patients who have undergone standard Kasai surgery develop a serious liver complication called portal hypertension (PH), and this is linked…

Huahui Health‘s Libevitug has become the first approved treatment for chronic hepatitis D virus (HDV) infection in China. The country’s National Medical Products Administration…

People who are exposed to more sunlight over their lifetimes are less likely to develop primary biliary cholangitis (PBC), a study shows. “This suggests…

An international group of patients, clinicians, and researchers has recommended a standardized set of clinical measurements to assess outcomes in intrahepatic cholestasis of pregnancy…

A combination of aerobic exercise and resistance exercise is most effective for reducing liver fat, according to a review of data from appropriately controlled clinical…

International Alagille Syndrome Awareness Day is tomorrow, Jan. 24, and the advocacy organization Alagille Syndrome Alliance is calling on the community to stand together…

After about two years of treatment with the experimental therapies tobevibart and elebsiran, nearly nine out of 10 evaluable…

Researchers have identified three proteins that may be key targets for treating primary sclerosing cholangitis (PSC), and one of these proteins may also be…

A global clinical trial testing Mirum Pharmaceuticals‘ maralixibat for treatment-resistant itching, or pruritus, associated with rare cholestatic conditions is expected to complete patient…